Post

Génome Québec invests up to $500,000 to boost RNA therapeutics innovation in Quebec

Montreal – October 2, 2024 – Génome Québec, a private, non-profit organization dedicated to advancing genomics research and innovation in Quebec, is investing up to $500,000 in McGill University’s D2R Initiative. This investment will advance the commercialization of innovative genomic technologies in Quebec through D2R’s Commercialization Priming funding program.  D2R’s Commercialization Priming funding program is…

See more